分子診断の市場規模、シェア、成長分析、製品別、検査タイプ別、サンプルタイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

分子診断の世界市場規模は2023年に158億米ドルと評価され、予測期間（2025-2032年）のCAGRは6.9%で、2024年の168億9,000万米ドルから2032年には288億米ドルに成長する見通しです。

世界の分子診断市場は、技術の進歩、感染症の蔓延の増加、個別化医療の台頭を背景に、大きな成長が見込まれています。この分野は、感染症、腫瘍学、遺伝性疾患、薬理ゲノミクスなど、さまざまな疾患に関連する生体分子の検出と特性解析を包含しています。PCR、NGS、マイクロアレイなどの最近の技術革新は、検査の感度と特異性を高め、より迅速で正確な診断を可能にしています。HIVや肝炎のような感染症の増加、高齢化、慢性疾患の蔓延が相まって、市場は顕著に拡大しており、早期発見と的を絞った治療のために信頼性の高い分子診断が必要とされています。アボット社、ロシュ社、サーモ・フィッシャー社などの主要企業は、市場での地位を強化するため、戦略的パートナーシップや製品のイノベーションを積極的に進めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 特許分析
• 規制分析
• 技術分析
• ケーススタディ

分子診断市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 試薬とキット
• 機器
• サービスとソフトウェア

分子診断市場規模：検査タイプ別& CAGR（2025-2032）

• 市場概要
• ラボテスト
• POCテスト

分子診断市場規模：サンプルタイプ別& CAGR（2025-2032）

• 市場概要
• 血液、血清、血漿
• 尿
• その他のサンプルタイプ

分子診断市場規模：技術別& CAGR（2025-2032）

• 市場概要
• ポリメラーゼ連鎖反応
• 等温核酸増幅技術
• DNAシーケンシングと次世代シーケンシング
• インサイチューハイブリダイゼーション
• DNAマイクロアレイ
• その他の技術

分子診断市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 感染症診断
  • 肝炎
  • B型肝炎
  • C型肝炎
  • その他の肝炎疾患
  • HIV
  • CT/NG
  • ハイ
  • HPV
  • 結核
  • インフルエンザ
  • その他の感染症
• 腫瘍学検査
  • 乳がん
  • 大腸がん
  • 肺がん
  • 前立腺がん
  • その他のがんの種類
• 遺伝子検査
• その他の用途

分子診断市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 診断検査室
• 病院と診療所
• その他のエンドユーザー

分子診断市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Hologic, Inc.（US）
• Abbott Laboratories（US）
• Illumina, Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• bioMerieux（France）
• QIAGEN（Netherlands）
• Becton Dickinson And Company（US）
• Grifols S.A.（Spain）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• Quidel Corporation（US）
• Biocartis（Belgium）
• DiaSorin（Italy）
• Myriad Genetics（US）
• Revvity（US）
• MDxHealth（Belgium）
• OncoCyte Corporation（US）

結論と提言

Global Molecular Diagnostics Market size was valued at USD 15.8 billion in 2023 and is poised to grow from USD 16.89 billion in 2024 to USD 28.8 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global molecular diagnostics market is poised for significant growth, driven by advancements in technology, increasing prevalence of infectious diseases, and the rise of personalized medicine. This sector encompasses the detection and characterization of biomolecules related to various conditions, including infectious diseases, oncology, genetic disorders, and pharmacogenomics. Recent innovations such as PCR, NGS, and microarrays have enhanced test sensitivity and specificity, enabling quicker and more accurate diagnoses. The market is notably expanding due to rising rates of infectious diseases like HIV and hepatitis, coupled with an aging population and escalating chronic disease prevalence, necessitating reliable molecular diagnostics for early detection and targeted treatments. Key players including Abbott, Roche, and Thermo Fisher are actively pursuing strategic partnerships and product innovations to strengthen their market position.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Market Segments Analysis

Global Molecular Diagnostics Market is segmented by Product, Test Type, Sample Type, Technology, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments and Services & Software. Based on Test Type, the market is segmented into Lab Tests and POC Tests. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays and Other Technologies. Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Diagnostics Market

The global molecular diagnostics market is being significantly propelled by the rapid advancements in technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and microarray technologies. These innovations have transformed the landscape of molecular diagnostics, leading to a marked improvement in the accuracy, sensitivity, and speed of diagnostic tests. As a result, the enhanced performance of these diagnostic tools has fostered greater market growth, enabling healthcare professionals to deliver more precise and timely results. This continuous evolution of diagnostic technology plays a crucial role in expanding the overall molecular diagnostics market, meeting the increasing demand for effective healthcare solutions.

Restraints in the Global Molecular Diagnostics Market

Despite the high accuracy and effectiveness of molecular diagnostic tests, their implementation is often hindered by high costs, particularly in developing regions where healthcare budgets are limited. The expenses associated with the necessary testing equipment, reagents, and the skilled personnel required for molecular testing can be substantial. This financial burden places considerable strain on healthcare facilities in these areas, ultimately restricting the growth of the Global Molecular Diagnostics market. Without addressing these cost-related challenges, widespread adoption and accessibility of molecular diagnostics remain a significant hurdle, hampering potential advancements in patient care and disease management.

Market Trends of the Global Molecular Diagnostics Market

The Global Molecular Diagnostics market is experiencing a significant shift towards point-of-care testing, propelled by the increasing demand for rapid diagnosis and effective treatment monitoring. This trend spans a variety of healthcare environments, including clinics, emergency rooms, and mobile health units, as healthcare providers prioritize timely interventions. Innovations in miniaturized and portable molecular diagnostic devices are facilitating real-time testing outside conventional laboratory settings, thereby improving patient care and operational efficiency. As a result, the market is witnessing an expansion in product offerings and technologies designed to meet the evolving needs of clinicians and patients alike, highlighting a transformative evolution in healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Molecular Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
• Instruments
• Services & Software

Global Molecular Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Lab Tests
• POC Tests

Global Molecular Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Molecular Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• In Situ Hybridization
• DNA Microarrays
• Other Technologies

Global Molecular Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Disease Diagnostics
  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other hepatitis diseases
  • HIV
  • CT/NG
  • HAI
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
• Oncology Testing
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer Types
• Genetic Testing
• Other Applications

Global Molecular Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Other End Users

Global Molecular Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Sample Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocartis (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MDxHealth (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OncoCyte Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations